Arcoma AB - Asset Resilience Ratio

Latest as of March 2016: 18.92%

Arcoma AB (ARCOMA) has an Asset Resilience Ratio of 18.92% as of March 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Arcoma AB's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Skr14.41 Million

≈ $1.55 Million USD Cash + Short-term Investments

Total Assets

Skr76.19 Million

≈ $8.20 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Arcoma AB's Asset Resilience Ratio has changed over time. See Arcoma AB (ARCOMA) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Arcoma AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ARCOMA market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr14.41 Million	18.92%
Total Liquid Assets	Skr14.41 Million	18.92%

Asset Resilience Insights

Good Liquidity Position: Arcoma AB maintains a healthy 18.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Arcoma AB Industry Peers by Asset Resilience Ratio

Compare Arcoma AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for Arcoma AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Arcoma AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$13.61 Million

Skr126.49 Million SEK

Market Cap Rank

#26270 Global

#558 in Sweden

Share Price

Skr8.84

Change (1 day)

-6.55%

52-Week Range

Skr6.92 - Skr10.75

All Time High

Skr25.60